First of all, through CXCL12-CXCR4 interaction between MSC and CML cells (respectively), imatinib-induced cell death is reduced as a consequence of attenuated caspase-3 activity [76]. This evidence concerns the gene CXCL12 and chronic myelogenous leukemia, BCR-ABL1 positive.